Collagen Dipeptide Pro-Hyp Identified as Growth Signal for Wound-Healing Fibroblasts | Research

The takeaway

The collagen-derived dipeptide prolylhydroxyproline (Pro-Hyp) selectively triggers growth of stem cell-like fibroblasts at wound sites, explaining why oral collagen supplements accelerate wound healing.

Selective fibroblast activation
Pro-Hyp activates wound-healing stem cell-like fibroblasts while leaving healthy tissue fibroblasts quiescent

What the researchers found

Pro-Hyp is a low molecular weight growth-initiating factor that selectively triggers proliferation of p75NTR-positive (stem cell-like) fibroblasts on collagen gel but not p75NTR-negative fibroblasts. Oral collagen/gelatin delivers Pro-Hyp to tissues and accelerates wound healing in animals and humans.

Why it matters

This provides a molecular explanation for why collagen supplements help wounds heal — a connection that was observed clinically but not mechanistically understood. It also identifies Pro-Hyp as a targetable factor for chronic wound therapy.

The numbers in context

Pro-Hyp dipeptide; selective for p75NTR+ fibroblasts on collagen; oral bioavailability confirmed; improves pressure ulcers and diabetic wounds

How the study worked

Review integrating cell biology studies of fibroblast heterogeneity, Pro-Hyp signaling on collagen substrates, and preclinical/clinical evidence for oral collagen supplementation in wound healing.

Who was studied

Not applicable (review covering in vitro, animal, and human wound healing studies)

What this study cannot tell us

Review — summarizes existing evidence without new data. The p75NTR selectivity mechanism needs further elucidation. Optimal Pro-Hyp doses for clinical wound healing not standardized.

How to read the evidence

Moderate — integrates cell biology with preclinical and clinical wound healing evidence, providing a mechanistic framework for observed clinical benefits.

When this study was published

Published in 2020; understanding of collagen peptide bioactivity continues to deepen.

The bigger picture

This is a rare example of a food-derived bioactive peptide with a clearly identified molecular target and clinical evidence, bridging nutraceutical science with wound healing biology.

Questions still open

What is the receptor or signaling pathway through which Pro-Hyp activates p75NTR-positive fibroblasts?
Could topical Pro-Hyp application be more effective than oral collagen for wound healing?
Does Pro-Hyp play a role in other collagen-dependent repair processes like tendon healing?

Common questions

Can taking collagen supplements actually help heal wounds?

Yes — clinical trials show oral collagen/gelatin supplements improve healing of pressure ulcers in humans and diabetic wounds in animals. This review identifies Pro-Hyp, a dipeptide absorbed from digested collagen, as the active mechanism.

How does a tiny two-amino-acid peptide from food reach wound sites?

When you eat collagen or gelatin, digestive enzymes break it into small peptides including Pro-Hyp. This dipeptide is absorbed intact from the gut into the bloodstream and delivered to tissues including wound sites, where it signals stem cell-like fibroblasts to grow and repair.

Read the original research

Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing.

Frontiers in cell and developmental biology, 8, 548975

View on PubMed ↗Publisher’s paper ↗

Citation

Sato, Kenji; Asai, Tomoko T; Jimi, Shiro. (2020). Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing.. Frontiers in cell and developmental biology, 8, 548975. https://doi.org/10.3389/fcell.2020.548975